Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008–2024) and pipeline phase III medications

Objective: This systematic review examines psychiatric medications approved by the FDA for anxiety disorders, post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) from 2008 to 2024 and describes the mechanism of action, indications for both labelled and off-label uses, evide...

Descripció completa

Dades bibliogràfiques

Autors principals:	Emile Tadros, Shirley Keerthana, Samar Padder, Jayant Totlani, Drew Hirsch, Daniel N Kaidbay, Lorena Contreras, Aasim Naqvi, Samuel Miles, Krista Mercado, Ashley Meyer, Sabrina Renteria, Robert N Pechnick, Itai Danovitch, Waguih William IsHak
Format:	Artigo
Idioma:	Inglês
Publicat:	BioExcel Publishing Ltd 2025-04-01
Col·lecció:	Drugs in Context
Matèries:	anxiety disorders fda-approved ocd psychiatric disorders psychiatric medications ptsd
Accés en línia:	https://www.drugsincontext.com/anxiety-disorders-ptsd-and-ocd-systematic-review-of-approved-psychiatric-medications-20082024-and-pipeline-phase-iii-medications/
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!